Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry. 3. Februar 2023 Metzenmacher M, Griesinger F, Hummel HD, Elender C, Schäfer H, de Wit M, Kaiser U, Kern J, Jänicke M, Spring L, Zacharias S, Kaiser-Osterhues A, Groth A, Hipper A, Zaun G, Dörfel S, Güldenzoph B, Müller L, Uhlig J, Thomas M, Sebastian M, Eberhardt WEE; CRISP Registry Group. Eur Respir J. 2023 Feb 2;61(2):2201336. doi: 10.1183/13993003.01336-2022. Link Checkpoint inhibitor monotherapy in potentially studyeligible or non-study-eligible NSCLC patients in the German CRISP Registry real-world cohort (AIO-TRK-0315). F Griesinger; M Sebastian; W Brückl; H-D Hummel; B Jaeschke; J Kern; C Wesseler; M Jänicke; A Fleitz; S Zacharias; A Hipper; A Groth; W… Weiterlesen Treatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPAL. Thill M, Zahn MO, Welt A, Stickeler E, Nusch A, Fietz T, Rauh J, Wetzel N, Kruggel L, Jänicke M, Marschner N, Harbeck N, Wöckel… Weiterlesen